Beam Therapeutics (BEAM) Retained Earnings (2019 - 2026)
Beam Therapeutics (BEAM) reported Retained Earnings of -$1.1 million for Q1 2026, down 768.75% year-over-year from $160000.0 in Q1 2025, and up 99.93% quarter-over-quarter from -$1.6 billion in Q4 2025.
Beam Therapeutics (BEAM) Retained Earnings (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Retained Earnings data on file, last reported at -$1.1 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.1 million, down 768.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 768.75% YoY), and the FY2025 annual result was -$1.6 billion, down 241811.19% from the prior year.
- Retained Earnings improved to -$1.1 million in Q1 2026 per BEAM's latest filing, from -$1.6 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $1.8 million in Q3 2024 and troughed at -$1.8 billion in Q2 2025.
- A 5-year average of -$662.6 million and a median of -$837.5 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings slumped 3489483.33% in 2022, then soared 186.91% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$1.1 billion in 2022, then dropped by 12.53% to -$1.2 billion in 2023, then jumped by 100.06% to $679000.0 in 2024, then sank by 241811.19% to -$1.6 billion in 2025, then soared by 99.93% to -$1.1 million in 2026.
- Business Quant data shows BEAM's Retained Earnings at -$1.1 million in Q1 2026, -$1.6 billion in Q4 2025, and $790000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - | -1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.07 Mn |
| Dec 31, 2025 | -1.64 Bn |
| Sep 30, 2025 | 790,000.00 |
| Jun 30, 2025 | -1.80 Bn |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 679,000.00 |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | -1.38 Bn |
| Mar 31, 2024 | -921,000.00 |
| Dec 31, 2023 | -1.19 Bn |
| Sep 30, 2023 | -2.02 Mn |
| Jun 30, 2023 | -1.20 Bn |
| Mar 31, 2023 | -1.15 Bn |
| Dec 31, 2022 | -1.06 Bn |
| Sep 30, 2022 | -1.00 Bn |
| Jun 30, 2022 | -4.19 Mn |
| Mar 31, 2022 | -837.50 Mn |
| Dec 31, 2021 | -50,000.00 |
| Sep 30, 2021 | -703.60 Mn |
| Jun 30, 2021 | -675.40 Mn |